Renaud Maire

641 total citations
7 papers, 205 citations indexed

About

Renaud Maire is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Renaud Maire has authored 7 papers receiving a total of 205 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Oncology and 3 papers in Neurology. Recurrent topics in Renaud Maire's work include Neuroendocrine Tumor Research Advances (6 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Neuroblastoma Research and Treatments (3 papers). Renaud Maire is often cited by papers focused on Neuroendocrine Tumor Research Advances (6 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Neuroblastoma Research and Treatments (3 papers). Renaud Maire collaborates with scholars based in Switzerland, Italy and United Kingdom. Renaud Maire's co-authors include Aurel Perren, Matthias S. Dettmer, Ilaria Marinoni, Annunziata Di Domenico, Cédric Simillion, Konstantin Bräutigam, Erik Vassella, Christodoulos P. Pipinikas, Marie-Hélène Wasmer and Marc‐David Ruepp and has published in prestigious journals such as Thyroid, Cancers and Neuroendocrinology.

In The Last Decade

Renaud Maire

6 papers receiving 201 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renaud Maire Switzerland 5 136 112 56 38 38 7 205
Dominik Wiese Germany 11 200 1.5× 180 1.6× 84 1.5× 58 1.5× 8 0.2× 15 273
Edoardo Biondi Italy 6 80 0.6× 63 0.6× 70 1.3× 18 0.5× 21 0.6× 14 188
Annunziata Di Domenico Switzerland 6 208 1.5× 215 1.9× 123 2.2× 41 1.1× 5 0.1× 10 273
Shlomit Jessel United States 6 96 0.7× 19 0.2× 17 0.3× 51 1.3× 56 1.5× 12 210
Leah Ensell United Kingdom 6 107 0.8× 66 0.6× 43 0.8× 13 0.3× 14 0.4× 12 129
Victoria E. Wang United States 4 109 0.8× 73 0.7× 31 0.6× 49 1.3× 8 0.2× 6 153
Yuichi Tachibana Japan 8 106 0.8× 102 0.9× 34 0.6× 27 0.7× 5 0.1× 29 190
Marcin Zeman Poland 6 85 0.6× 35 0.3× 14 0.3× 47 1.2× 6 0.2× 25 185
José Luis Manzano Mozo Spain 5 155 1.1× 62 0.6× 40 0.7× 23 0.6× 6 0.2× 15 176
Diana Shinko Australia 6 80 0.6× 17 0.2× 11 0.2× 57 1.5× 73 1.9× 12 206

Countries citing papers authored by Renaud Maire

Since Specialization
Citations

This map shows the geographic impact of Renaud Maire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renaud Maire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renaud Maire more than expected).

Fields of papers citing papers by Renaud Maire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renaud Maire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renaud Maire. The network helps show where Renaud Maire may publish in the future.

Co-authorship network of co-authors of Renaud Maire

This figure shows the co-authorship network connecting the top 25 collaborators of Renaud Maire. A scholar is included among the top collaborators of Renaud Maire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renaud Maire. Renaud Maire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Domenico, Annunziata Di, Philipp Kirchner, Konstantin Bräutigam, et al.. (2025). Molecular Subtypes of Pancreatic Neuroendocrine Tumors Mutated in MEN1/DAXX/ATRX Explain Biological Variability. Endocrine Pathology. 36(1). 44–44.
2.
April-Monn, Simon, Philipp Kirchner, Katharina Detjen, et al.. (2024). Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies. npj Precision Oncology. 8(1). 59–59. 4 indexed citations
3.
April-Monn, Simon, Valentina Andreasi, Marco Schiavo Lena, et al.. (2021). EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs). Cancers. 13(19). 5014–5014. 17 indexed citations
4.
April-Monn, Simon, Tabea Wiedmer, Renaud Maire, et al.. (2020). Three-Dimensional Primary Cell Culture: A Novel Preclinical Model for Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 111(3). 273–287. 38 indexed citations
5.
Domenico, Annunziata Di, Christodoulos P. Pipinikas, Renaud Maire, et al.. (2020). Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression. Communications Biology. 3(1). 740–740. 68 indexed citations
6.
Lena, Marco Schiavo, Maria Giulia Cangi, Lorenza Pecciarini, et al.. (2020). Evidence of a common cell origin in a case of pancreatic mixed intraductal papillary mucinous neoplasm–neuroendocrine tumor. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 478(6). 1215–1219. 13 indexed citations
7.
Schürch, Christian M., Stefan Förster, Marie-Hélène Wasmer, et al.. (2019). Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy. Thyroid. 29(7). 979–992. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026